Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta

• Published in: Biomaterials Vol. 27; no. 28; pp. 4955 - 4962
• Main Authors: Peuster, Matthias, Hesse, Carola, Schloo, Tirza, Fink, Christoph, Beerbaum, Philipp, von Schnakenburg, Christian
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.10.2006
• Subjects: Animals; Aorta, Thoracic - surgery; Biodegradation; Blood Vessel Prosthesis Implantation - methods; Blood Vessels - pathology; Corrosion; Degradation; Intimal hyperplasia; Iron - metabolism; Iron - pharmacokinetics; Male; Materials Testing - methods; Stent; Stents; Swine; Swine, Miniature; Tissue Distribution; Biodegradation; Degradation; Corrosion; Intimal hyperplasia; Stent
• ISSN: 0142-9612; 1878-5905
• DOI: 10.1016/j.biomaterials.2006.05.029

Currently there are no biodegradable stents available for treatment of vascular obstructions in patients with congenital heart defects. This study was performed to evaluate the safety of a corrodible stent produced from pure iron in a peripheral stent design (6–12 mm diameter) in a slotted tube design similar to a commercially available 316-L stent which served as control. Both stents were implanted into the descending aorta of 29 minipigs with an overstretch injury without technical problems. Two animals died after the implantation not related to the iron stent. The remaining 27 minipigs were followed for 1–360 days. Histomorphometry and quantitative angiography showed no difference with regard to the amount of neointimal proliferation between 316-L and iron stents. Histopathological examination of heart, lung, spleen, liver, kidney and para-aortic lymphatic nodes demonstrated no signs of iron overload or iron-related organ toxicity. Adjacent to the iron stent struts, there was no evidence for local toxicity due to corrosion products. We conclude that iron is a suitable metal for the production of a large-size degradable stent with no local or systemic toxicity. A faster degradation rate, however, is desirable and further studies have to focus on the modification of the composition and design of the stent to expedite the degradation process.